Literature DB >> 28856372

Erratum to: Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA.

Murat Fani Bozkurt1, Irene Virgolini2, Sona Balogova3,4, Mohsen Beheshti5,6, Domenico Rubello7, Clemens Decristoforo2, Valentina Ambrosini8, Andreas Kjaer9, Roberto Delgado-Bolton10, Jolanta Kunikowska11, Wim J G Oyen12, Arturo Chiti13, Francesco Giammarile14, Anders Sundin15, Stefano Fanti8.   

Abstract

Entities:  

Year:  2017        PMID： 28856372     DOI： 10.1007/s00259-017-3807-0

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  2 in total

1.  Can Q.Clear reconstruction be used to improve [68 Ga]Ga-DOTANOC PET/CT image quality in overweight NEN patients?

Authors:  Lucia Zanoni; Giulia Argalia; Emilia Fortunati; Claudio Malizia; Vincenzo Allegri; Diletta Calabrò; Simona Civollani; Davide Campana; Stefano Fanti; Valentina Ambrosini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-10-25       Impact factor: 9.236

Review 2.  Application of molecular probes in nuclear imaging of neuroendocrine tumors.

Authors:  Jing Yan; Tingting Zhang; Kui Zhao
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-02-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.